Skip to main content

Prism Capital Partners’ ON3 Earns Prestigious ULI-NNJ Excellence Award

Prism Capital Partners and its ON3 development this spring were honored by the Urban Land Institute, Northern New Jersey chapter (ULI-NNJ) during the esteemed organization’s annual Excellence Awards Gala. ON3 earned top prize in the Suburban Redevelopment category.

Eisai Opens New U.S. HQ at ON3 Campus; Will Bring 800 Jobs to Nutley

Eisai Inc., the U.S. pharmaceutical subsidiary of Japan’s Eisai Co. Ltd., officially relocated its U.S. headquarters from Woodcliff Lake to the ON3 complex in Nutley. The move brings approximately 800 jobs to the area and, at full capacity, the new state-of-the-art facility will accommodate 1,300 employees.

Eisai Inc. Opens New US Headquarters on ON3 Campus in Nutley

Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., has relocated its US headquarters to the ON3 Campus at 200 Metro Blvd. in Nutley. The move supports Eisai’s new hybrid workstyle and human health care mission to deliver life-changing therapies and health-related solutions.

Eisai Pharmaceuticals to Occupy Iconic Tower at ON3 in Nutley February 2022

Eisai, an oncology and neurology-focused pharmaceutical company, is moving to Nutley in February. The Japanese firm will occupy the entire iconic 15-story International style tower that anchors the life-science campus straddling the border of the Township of Nutley and City of Clifton.

New Jersey Has Many Blessings to Count

Our Office Deal of the Year finalists — Park Avenue at Morris County, Lincoln Equities Group and HIG Realty Partners’ acquisition of the Bristol-Myers Squibb campus in Hopewell and the winner, Eisai Inc.’s headquarters lease at Prism Capital Partners’ ON3 in Nutley — are evidence that the office sector has a strengthening pulse.